Clinical Trial Update: COVID-19 Antibody Responses in Cystic Fibrosis [NA]

View source ↗

Summary

A clinical trial update reports on COVID-19 antibody responses in individuals with cystic fibrosis; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis

Snippet

Sponsor: Hospices Civils de Lyon | Conditions: COVID-19, Cystic Fibrosis | NA | Status: COMPLETED